← Leaderboards
Nevil John Singh
University Of Maryland Baltimore
$6,357,358
Attributed
$11,274,990
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2014–25$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,274,990 · 7
By mechanism
R01$9,617,417 · 3
R21$1,273,823 · 3
R56$383,750 · 1
Top collaborators
- Alexander Andrianov5 shared
- Thomas R Fuerst5 shared
- Roy A Mariuzza5 shared
- Gilad A Ofek5 shared
- Brian G. Pierce5 shared
- Alexander Ploss5 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Charles D Howell$4,304,760
- Michy Patrice Kelly$6,411,201
- Christopher V. Plowe$27,953,996
- Roger Keith Reeves$28,096,305
- George Thomas Strickland$3,181,160
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteImmunityImmune ResponseResponseAntigensSignal TransductionCellsT Cell ResponseVaccinesLeadMolecularAffectInfectionCytokinePathway InteractionsMediatingProteinsBiochemicalPathogenDesignImmunizationBasePreventEnsure
Grant awards (20)
Rational design and efficacy testing of vaccines against HCV$1,357,012
R01 · FY2025 · AI
Mechanisms coordinating the local and systemic resistance to pathogens$578,188
R01 · FY2025 · AI · contact PI
Rational design and efficacy testing of vaccines against HCV$1,410,043
R01 · FY2024 · AI
Mechanisms coordinating the local and systemic resistance to pathogens$596,070
R01 · FY2024 · AI · contact PI
Rational design and efficacy testing of vaccines against HCV$179,958
R01 · FY2024 · AI
Rational design and efficacy testing of vaccines against HCV$1,379,680
R01 · FY2023 · AI
Mechanisms coordinating the local and systemic resistance to pathogens$609,077
R01 · FY2023 · AI · contact PI
Rational design and efficacy testing of vaccines against HCV$1,410,544
R01 · FY2022 · AI
An IL-12 family heterodimer that regulates IL-4 production by T cells$193,125
R21 · FY2022 · AI · contact PI
An IL-12 family heterodimer that regulates IL-4 production by T cells$231,750
R21 · FY2021 · AI · contact PI
Mechanisms maintaining the self-awareness of peripheral T cells$231,750
R21 · FY2021 · AI · contact PI
Mechanisms maintaining the self-awareness of peripheral T cells$193,125
R21 · FY2020 · AI · contact PI
Role of sub-activation-threshold TCR interactions in maintaining T cell memory$383,750
R01 · FY2019 · AI · contact PI
Role of sub-activation-threshold TCR interactions in maintaining T cell memory$383,750
R01 · FY2018 · AI · contact PI
Role of sub-activation-threshold TCR interactions in maintaining T cell memory$576,638
R01 · FY2017 · AI · contact PI
JEDI negatively regulates TCR-signaling in chronically-stimulated T cells$193,073
R21 · FY2017 · AI · contact PI
Role of sub-activation-threshold TCR interactions in maintaining T cell memory$369,015
R01 · FY2016 · AI · contact PI
JEDI negatively regulates TCR-signaling in chronically-stimulated T cells$231,000
R21 · FY2016 · AI · contact PI
Role of sub-activation-threshold TCR interactions in maintaining T cell memory$383,692
R01 · FY2015 · AI · contact PI
Modifying T Cell Responses by Combinatorial Targeting of Negative regulators$383,750
R56 · FY2014 · AI · contact PI